AI-generated summary
The authors randomized 36 people with Parkinson's disease to bright light therapy at high or low illuminance in a double-blind, placebo-controlled pilot study. They report significant improvement in tremor, several motor and daily-living scores, and depression in the active treatment group but not in the placebo group, with small overall group differences and good tolerability.
- Participants
- 36
- Who or what was studied
- People with Parkinson's disease
- Limits stated in the abstract
- The abstract describes this as a pilot study with small group differences, and it calls for follow-up studies in more advanced patients and longer treatment durations.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on movementdisorders.onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Pilot study, Depression, Lux, Light-emitting diode, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.